PAR 5.26% 18.0¢ paradigm biopharmaceuticals limited..

Where we at?, page-57

  1. 35 Posts.
    lightbulb Created with Sketch. 20
    This is an issue for me, that different groups of investors operate with different sets of information provided by the company.

    I understand that continuous disclosure could be detrimental and by no means suggest they are breaking ASX rules. However, it is not fair that some know more than others and it doesn't look good for the company when gossip, word of mouth and forums inform investors more than the company itself.

    And I also don't think that calling Simon weekly should be required in order to know what is going on in a company you are a part owner of. If information not provided publicly, it shouldn't be provided privately.

    Mozz, others, you have to agree this is not a good look.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
18.0¢
Change
-0.010(5.26%)
Mkt cap ! $68.29M
Open High Low Value Volume
19.0¢ 20.0¢ 18.0¢ $490.4K 2.614M

Buyers (Bids)

No. Vol. Price($)
12 241421 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 45280 4
View Market Depth
Last trade - 15.23pm 25/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.